OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today announced U.S. Food and Drug Administration (FDA) ...
“You have to defend yourself,” she tells Prevention.
Urteste S.A. enrolls the first patient in the Panuri test clinical studyGdańsk, Poland – 10 June 2026 – Urteste S.A. (Warsaw Stock Exchange: ...
The first thing she noticed on her screening panel was the word “HIGH” in red text: the test had detected elevated antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results